TLX101-Tx

· Telix Pharmaceuticals (Innovations) Pty Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TLX101-Tx, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma [Phase 3]

See pricing